These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34904813)

  • 41. DNA damage response inhibitors: An avenue for TNBC treatment.
    Jin J; Tao Z; Cao J; Li T; Hu X
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insights into checkpoint kinase 1 in the DNA damage response signaling network.
    Dai Y; Grant S
    Clin Cancer Res; 2010 Jan; 16(2):376-83. PubMed ID: 20068082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The interplay between DNA repair and autophagy in cancer therapy.
    Zhang D; Tang B; Xie X; Xiao YF; Yang SM; Zhang JW
    Cancer Biol Ther; 2015; 16(7):1005-13. PubMed ID: 25985143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications.
    Sun W; Zhang Q; Wang R; Li Y; Sun Y; Yang L
    Front Oncol; 2021; 11():648687. PubMed ID: 34026622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic vulnerabilities upon inhibition of DNA damage response.
    Wang C; Tang M; Chen Z; Nie L; Li S; Xiong Y; Szymonowicz KA; Park JM; Zhang H; Feng X; Huang M; Su D; Hart T; Chen J
    Nucleic Acids Res; 2021 Aug; 49(14):8214-8231. PubMed ID: 34320214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The DNA Damaging Revolution: PARP Inhibitors and Beyond.
    Yap TA; Plummer R; Azad NS; Helleday T
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():185-195. PubMed ID: 31099635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
    Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
    PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
    Yan S; Sorrell M; Berman Z
    Cell Mol Life Sci; 2014 Oct; 71(20):3951-67. PubMed ID: 24947324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
    Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
    DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression.
    Lin SY; Liang Y; Li K
    Yonsei Med J; 2010 May; 51(3):295-301. PubMed ID: 20376879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice.
    Helleday T
    Curr Opin Oncol; 2013 Nov; 25(6):609-14. PubMed ID: 24097104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers.
    Przybycinski J; Nalewajska M; Marchelek-Mysliwiec M; Dziedziejko V; Pawlik A
    Expert Opin Ther Targets; 2019 Sep; 23(9):773-785. PubMed ID: 31394942
    [No Abstract]   [Full Text] [Related]  

  • 54. DNA damage in cancer therapeutics: a boon or a curse?
    Khanna A
    Cancer Res; 2015 Jun; 75(11):2133-8. PubMed ID: 25931285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
    Wang M; Chen S; Ao D
    MedComm (2020); 2021 Dec; 2(4):654-691. PubMed ID: 34977872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Fidelity Deep Sequencing Reveals No Effect of ATM, ATR, and DNA-PK Cellular DNA Damage Response Pathways on Adenovirus Mutation Rate.
    Risso-Ballester J; Sanjuán R
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.
    Al-Ejeh F; Kumar R; Wiegmans A; Lakhani SR; Brown MP; Khanna KK
    Oncogene; 2010 Nov; 29(46):6085-98. PubMed ID: 20818418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
    Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
    Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
    Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.